150 related articles for article (PubMed ID: 37304648)
21. Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis.
Jiang G; Liu YQ; Wei ZP; Pei DS; Mao LJ; Zheng JN
Cancer Lett; 2010 Aug; 294(2):220-8. PubMed ID: 20189296
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
Qin H; Liu W
J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
Wang G; Fang X; Han M; Wang X; Huang Q
Int J Mol Med; 2018 Mar; 41(3):1740-1748. PubMed ID: 29328362
[TBL] [Abstract][Full Text] [Related]
24. B16 and cloudman S91 mouse melanoma cells susceptibility to apoptosis after dacarbazine treatment.
Olszewska-Słonina DM; Styczyńisk J; Drewa TA; Olszewski KJ; Czajkowski R
Acta Pol Pharm; 2005; 62(6):473-83. PubMed ID: 16583988
[TBL] [Abstract][Full Text] [Related]
25. Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73.
Thangasamy T; Sittadjody S; Mitchell GC; Mendoza EE; Radhakrishnan VM; Limesand KH; Burd R
BMC Cancer; 2010 Jun; 10():282. PubMed ID: 20540768
[TBL] [Abstract][Full Text] [Related]
26. Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathways.
Liu S; Gao G; Yan D; Chen X; Yao X; Guo S; Li G; Zhao Y
Cancer Med; 2017 Apr; 6(4):819-833. PubMed ID: 28332309
[TBL] [Abstract][Full Text] [Related]
27. Silencing of Dicer enhances dacarbazine resistance in melanoma cells by inhibiting ADSL expression.
Yeh YW; Hsu TW; Su YH; Wang CH; Liao PH; Chiu CF; Tseng PC; Chen TM; Lee WR; Tzeng YS
Aging (Albany NY); 2023 Nov; 15(22):12873-12889. PubMed ID: 37976135
[TBL] [Abstract][Full Text] [Related]
28. Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity.
Ding B; Wu X; Fan W; Wu Z; Gao J; Zhang W; Ma L; Xiang W; Zhu Q; Liu J; Ding X; Gao S
Int J Nanomedicine; 2011; 6():1991-2005. PubMed ID: 21976975
[TBL] [Abstract][Full Text] [Related]
29. Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells.
Engesæter BO; Sathermugathevan M; Hellenes T; Engebråten O; Holm R; Flørenes VA; Mælandsmo GM
Cancer Biol Ther; 2011 Jul; 12(1):47-58. PubMed ID: 21508672
[TBL] [Abstract][Full Text] [Related]
30. Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.
Long J; Menggen Q; Wuren Q; Shi Q; Pi X
Med Sci Monit; 2018 Mar; 24():1547-1559. PubMed ID: 29543785
[TBL] [Abstract][Full Text] [Related]
31. miR-942-5p promotes the proliferation and invasion of human melanoma cells by targeting DKK3.
Zhang W; Mao K; Liu S; Xu Y; Ren J
J Recept Signal Transduct Res; 2021 Apr; 41(2):180-187. PubMed ID: 32772782
[TBL] [Abstract][Full Text] [Related]
32. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
[TBL] [Abstract][Full Text] [Related]
33. Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice.
Thallinger C; Werzowa J; Poeppl W; Kovar FM; Pratscher B; Valent P; Quehenberger P; Joukhadar C
J Invest Dermatol; 2007 Oct; 127(10):2411-7. PubMed ID: 17508024
[TBL] [Abstract][Full Text] [Related]
34. Sensitization of melanoma cells to temozolomide by overexpression of microRNA 203 through direct targeting of glutaminase-mediated glutamine metabolism.
Chang X; Zhu W; Zhang H; Lian S
Clin Exp Dermatol; 2017 Aug; 42(6):614-621. PubMed ID: 28597996
[TBL] [Abstract][Full Text] [Related]
35. [Dubovtseva IY; Aksenenko MB; Nikolaeva ED; Averchuk AS; Moshev AV; Savchenko AA; Markova SV; Ruksha TG
Mol Biol (Mosk); 2021; 55(4):667-675. PubMed ID: 34432784
[TBL] [Abstract][Full Text] [Related]
36. Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines.
Lillehammer T; Engesaeter BO; Prasmickaite L; Maelandsmo GM; Fodstad O; Engebraaten O
J Gene Med; 2007 Jun; 9(6):440-51. PubMed ID: 17410615
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-150-5p affects cell proliferation, apoptosis, and EMT by regulation of the BRAF
Yan R; Yang T; Zhai H; Zhou Z; Gao L; Li Y
J Cell Biochem; 2018 Nov; 119(11):8763-8772. PubMed ID: 30126001
[TBL] [Abstract][Full Text] [Related]
38. miR-590-5p Targets Skp2 to Inhibit the Growth and Invasion of Malignant Melanoma Cells.
Tong Y; Jin L
Dis Markers; 2022; 2022():8723725. PubMed ID: 35845132
[TBL] [Abstract][Full Text] [Related]
39. MiR-186 inhibits cell proliferation and invasion in human cutaneous malignant melanoma.
Su BB; Zhou SW; Gan CB; Zhang XN
J Cancer Res Ther; 2018; 14(Supplement):S60-S64. PubMed ID: 29578151
[TBL] [Abstract][Full Text] [Related]
40. Effect of dacarbazine on CD44 in live melanoma cells as measured by atomic force microscopy-based nanoscopy.
Huang X; He J; Zhang HT; Sun K; Yang J; Wang H; Zhang H; Guo Z; Zha ZG; Zhou C
Int J Nanomedicine; 2017; 12():8867-8886. PubMed ID: 29296081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]